The role of adiponectin-AMPK axis in TDP-43 mislocalization and disease severity in ALS
Open Access
- 30 October 2024
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 202, 106715
Abstract
No abstract availableKeywords
Funding Information
- Academia Sinica
- Institute of Biomedical Sciences Academia Sinica (AS-TP-109-LM08)
This publication has 53 references indexed in Scilit:
- Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosisJournal of Neurology, 2021
- Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker ResearchMolecular Neurobiology, 2020
- Energy metabolism in ALS: an underappreciated opportunity?Acta Neuropathologica, 2018
- AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral SclerosisNeurochemical Research, 2015
- Adiponectin and energy homeostasisReviews in Endocrine and Metabolic Disorders, 2013
- Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosisMuscle & Nerve, 2011
- Adiponectin Regulation and Function2011
- Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutationsActa Neuropathologica, 2010
- Hypermetabolism in ALS patients: an early and persistent phenomenonJournal of Neurology, 2009
- Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neuronsDevelopmental Dynamics, 1992